Sunday, May 3, 2020

Maryland Board of Pharmacy Guidance and Announcements Regarding COVID-19

COVID-19 Maryland Board of Pharmacy Guidance and Announcements

Maryland Board of Pharmacy Guidance on FDA Temporary Compounding policy 
April 22, 2020
 

Earlier this week the FDA issued temporary policy guidance on compounding of certain drugs for hospital patients by pharmacy compounders not registered as outsourcing facilities.

The Maryland Board of  Pharmacy generally supports the policy.  However, Maryland-licensed pharmacies that want to implement this temporary policy will be required to submit their request in writing to the board for consideration.  Board authorization is required before any pharmacy may provide compounded products under the auspices of this FDA policy guidance.  

Requests and inquiries should be submitted to

mdh.mdbop@maryland.gov  

-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)